Gregory Lo

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings

Gregory Lo, David Juhl, Theodore E. Warkentin et al. · Journal of Thrombosis and Haemostasis · 2006 · 998 citations · Full text

Medicine, Hematology, Diagnostic Assessment +8

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer

Matti Annala, Werner J. Struss, Evan W. Warner et al. · European Urology · 2017 · 218 citations

Life Sciences, Genetics, Oncology +14

What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?

Gregory Lo, Christopher Sigouin, Theodore E. Warkentin · American Journal of Hematology · 2007 · 202 citations · Full text

Life Sciences, Hematology, Immunology +11

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

Santiago Ponce Aix, Tudor–Eliade Ciuleanu, Alejandro Navarro et al. · The Lancet Respiratory Medicine · 2022 · 120 citations · Full text

Medicine, Oncology, Pharmacology +11

Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial

Matti Annala, Simon Fu, Jack V. W. Bacon et al. · Annals of Oncology · 2021 · 71 citations

Medicine, Oncology, Pharmacology +14